Olivier Graf

Novartis (Switzerland)

Papers

1

Total Citations

47

H-Index

1

About

Olivier Graf is a leading figure in biopharmaceutical process development, with a primary focus on the high-throughput formulation and characterization of therapeutic antibodies. His seminal work, "Formulation Development of Antibodies Using Robotic System and High-Throughput Laboratory (HTL)," published in 2009, has garnered 47 citations and stands as a cornerstone in the field. This research pioneered the integration of robotic automation and miniaturized laboratory workflows to accelerate the traditionally slow, manual process of antibody formulation, enabling rapid screening of stability, viscosity, and excipient compatibility. Graf’s contributions have directly impacted the speed and efficiency of preclinical development for monoclonal antibody therapeutics, reducing material consumption and enabling data-rich decision-making. His work is widely recognized for bridging the gap between automation technology and practical bioprocessing, influencing subsequent advances in high-throughput analytics. By demonstrating that robotic systems could reliably handle complex protein solutions, Graf helped establish a new paradigm for early-stage drug development, making him a key innovator in the biotech industry.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Formulation Development of Antibodies Using Robotic System and High-Throughput Laboratory (HTL)
47 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago